Age-related diseases are frequently linked to pathological immune dysfunction, including
excessive inflammation, autoreactivity and immunodeficiency. Recent analyses of human …

VEXAS syndrome (vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic) is a
monogenic disease of adulthood caused by somatic mutations in UBA1 in hematopoietic …

Objective. We describe myelodysplastic syndrome (MDS)–associated systemic inflammatory
and autoimmune diseases (SIADs), their treatments and outcomes and the impact of SIADs …

Autoimmune disorders (ADs) are encountered in 10 to 20% of patients with myelodysplastic
syndromes (MDS). Available data suggest that ADs concern more often younger patients …

Myelodysplastic syndrome (MDS) is a heterogeneous hematological malignancy,
characterized by cytopenia and accompanied by a risk of transformation into acute myeloid …

Objective The presence of systemic and/or immune manifestations in myelodysplasia has
been currently reported. The influence of these manifestations on the natural outcome of …

The coexistence of autoimmune disorders (AD) in patients with myelodysplastic syndrome
(MDS) or chronic myelomonocytic leukemia (CMML) has been widely recognized, although …

Myelodysplastic syndromes (MDS) are a set of oligoclonal disorders of hematopoietic stem
cells characterized by ineffective hematopoiesis that manifest clinically as anemia …

Chronic myelomonocytic leukemia (CMML) is a clonal hematopoietic stem cell disorder with
overlap** features of myelodysplastic syndromes (MDS) and myeloproliferative …

Our objective was to recognize the association of autoimmune diseases (AD) in patients with
myelodysplastic syndromes (MDS) and understand how this association could affect …